Research

Setting ART initiation targets in response to changing guidelines: The importance of addressing both steady-state and backlog

Catherine Martin, Nicolette P Naidoo, W D Francois Venter, Ambereen Jaffer, Pierre M Barker

Abstract


Background. Target setting is useful in planning, assessing and improving antiretroviral treatment (ART) programmes. In the past 4 years, the ART initiation environment has been transformed due to the change in eligibility criteria (starting ART at a CD4+ count <350 cells/μl v. <200 cells/μl) and the roll-out of nurse-initiated management of ART.

Objective. To describe and illustrate the use of a target-setting model for estimating district-based targets in the era of an expanding ART programme and changing CD4+ count thresholds for ART initiation.

Method. Using previously described models and data for annual new HIV infections, we estimated both steady-state need for ART initiation and backlog in a North West Province district, accounting for the shift in eligibility. Comparison of actual v. targeted ART initiations was undertaken. The change in CD4+ count threshold adds a once-off group of newly eligible patients to the pool requiring ART – the backlog. The steady-state remains unchanged as it is determined by the annual rate of new HIV infections in previous years.

Results. The steady-state need for the district was 639 initiations/month, and the backlog was ~15 388 patients. After the shift in eligibility in September 2011, the steady-state target was exceeded over several months with some backlog addressed. Of the total backlog for this district, 72% remains to be cleared.

Conclusion. South Africa has two pools of patients who need ART: the steady-state of HIV-infected patients entering the programme each year, determined by historical infection rates; and the backlog created by the shift in eligibility. The healthcare system needs to build long- term capacity to meet the steady-state need for ART and additional capacity to address the backlog. 


Authors' affiliations

Catherine Martin, Wits Reproductive Health and HIV Institute, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa

Nicolette P Naidoo, Wits Reproductive Health and HIV Institute, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa

W D Francois Venter, Wits Reproductive Health and HIV Institute, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa; Department of Medicine, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa

Ambereen Jaffer, Wits Reproductive Health and HIV Institute, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa

Pierre M Barker, Institute for Healthcare Improvement, Cambridge, Massachusetts, USA; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, North Carolina, USA

Full Text

PDF (123KB)

Keywords

Antiretroviral treatment; Target setting; ART roll-out

Cite this article

South African Medical Journal 2014;104(6):428-430. DOI:10.7196/SAMJ.7507

Article History

Date submitted: 2013-09-16
Date published: 2014-05-12

Article Views

Abstract views: 3765
Full text views: 1161

Comments on this article

*Read our policy for posting comments here